Alcor Life Extension

Press Release

Scottsdale, AZ, March 10, 2014 --(PR.com)-- Androklis Polymenis, a digital currency entrepreneur, has recently donated 1 million NXT coins to the Alcor Life Extension Foundation located in Scottsdale, Arizona.

After Alcor converted the 1 million NXT coin donation by Polymenis to bitcoins (and then to dollars) the end result was an approximately $44,000 donation to Alcor. The donation will be used to enhance marketing efforts, special projects and continued day to day operations at Alcor.

Alcor President, Max More, said that “This was a wonderful surprise to our foundation. Alcor would like to extend our sincerest gratitude to Mr. Polymenis for his kindness and generous financial contribution. This donation will help us continue our research and bring greater awareness of the possibilities of cryonics to a wider audience.”

Androklis Polymenis, a 37-year-old digital currency entrepreneur was born in Thessaloniki, Greece and went on to complete a degree in Computer Science. He has worked as a software developer as well as a computer science teacher for high school students. In 2011, Androklis discovered Bitcoin and was completely amazed by this revolutionary platform. He quickly grasped the enormous potential of the technology and went on to become one of the early investors in NXT digital currency.

Today, Polymenis has committed his full attention to the exploding field of cryptocurrencies and his own startup company UbiCrypt, with the goal of providing innovative solutions for NXT. In his spare time Androklis works on bringing together the words of promising disruptive technologies such as digital currency and life extension, with the goal of sparking greater public awareness and support for both.

The donation to Alcor was facilitated with the help of Nikola Danaylov, founder of SingularityWeblog.com and host of the popular Singularity 1 on 1 podcast.

About Alcor

The Alcor Life Extension Foundation, a non-profit organization founded in 1972, is the world leader in cryonics, and cryonics research and technology. Alcor performed its first human cryopreservation in 1976. Since then, Alcor has engaged in long-term patient care as well as cryopreservation procedures. Among Alcor’s scientific achievements is the use of advanced cryoprotectant formulas capable of vitrification. Today, Alcor is the only full-service cryonics organization in existence. Alcor has almost 1,000 members with arrangements to be cryopreserved upon legal death and 112 patients cryopreserved. For more information about Alcor and cryonics, visit www.alcor.org.